DTTC-Connect for Apraxia

This trial explores a new method called Dynamic Temporal and Tactile Cueing - Connect (DTTC-Connect) to assist children with childhood apraxia of speech (CAS), a condition that hinders clear speech. The treatment aims to enhance their ability to use connected speech, or speaking in phrases, which often poses a challenge. The trial involves children practicing phrase-level speech twice a week for eight weeks. Children diagnosed with CAS, who can repeat 2-3 word phrases, and speak English as their primary language might be suitable candidates for this trial. As an unphased trial, this study offers a unique opportunity for children to potentially benefit from innovative speech therapy techniques.

Research has shown that Dynamic Temporal and Tactile Cueing (DTTC) is a safe and effective treatment for children with childhood apraxia of speech (CAS). Studies consistently find that motor-based treatments like DTTC help children with CAS improve their ability to say words. Importantly, no major reports of negative side effects from DTTC have emerged, indicating that children tolerate it well. DTTC-Connect, the treatment under study, builds on the proven DTTC method and aims to help children improve their speech in sentences. Since evidence backs DTTC, it is considered a safe option for treating speech disorders.¹²³⁴⁵

Researchers are excited about DTTC-Connect for apraxia because it offers a new way to help individuals improve their speech abilities. Unlike traditional speech therapy methods, which often use static cues, DTTC-Connect employs Dynamic Temporal and Tactile Cueing. This unique approach uses a combination of timing and touch to guide speech production, potentially making it more effective for those with apraxia. By incorporating immediate feedback and tactile signals, DTTC-Connect aims to enhance motor learning and speech accuracy more efficiently than existing treatments.

Research has shown that Dynamic Temporal and Tactile Cueing (DTTC) helps children with childhood apraxia of speech (CAS) improve their ability to say words. This treatment teaches children to better control their speech muscles for clearer speech. Although few studies focus specifically on DTTC-Connect, DTTC itself has significantly enhanced children's speech clarity and accuracy. This trial will evaluate DTTC-Connect, which extends the method to aid in speaking phrases and sentences. The structured approach of DTTC-Connect aims to support this development, potentially improving overall communication skills. Participants in this trial will join either an Immediate Treatment Group or a Delayed Treatment Group to assess DTTC-Connect's effectiveness over time.⁶⁷⁸⁹¹⁰